Abstract 4137914: Eligibility for Semaglutide in US Adults with Diabetes and Potentially Preventable Cardiovascular Events Projected from the SUSTAIN-6 Trial
Year: 2024
Type: conference-abstract
Source: Circulation
Authors: Nathan Wong, Hridhay Karthikeyan, WENJUN FAN
Institution: University of California, Irvine
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4404323478
